top of page


ARA-290, a promising new cure for back pain?
Chronic nerve pain is one of the most difficult conditions to treat in modern medicine. Disorders such as neuropathy, nerve injury, and sciatica often persist despite the use of conventional medications like antidepressants, anticonvulsants, or opioids. In recent years, researchers have begun exploring novel biological therapies that address the underlying mechanisms of nerve damage rather than simply masking symptoms. One emerging compound attracting attention is ARA-290 , a
treabert
Mar 134 min read


The Case for Combining Selank and Semax for Cognitive Performance
In the search for improved mental performance, researchers and biohackers alike have increasingly turned their attention to neuropeptides —small protein fragments that influence brain signaling and neurological function. Among the most widely discussed cognitive peptides are Semax and Selank , two compounds originally developed by Russian scientists to support neurological health and cognitive resilience. Individually, both peptides demonstrate unique effects on brain chemis
treabert
Mar 134 min read


Retatrutide, and its surprising effect on tumors.
The idea that an obesity drug could reduce cancer risk seems counterintuitive at first, but when you look at the biology of cancer metabolism it starts to make sense. Drugs like Retatrutide affect several systems that are deeply involved in how tumors grow. Below are the main mechanisms researchers think may explain the potential anti-cancer effects. 1. Lower insulin removes a major tumor growth signal One of the strongest links between obesity and cancer is chronically elev
treabert
Mar 133 min read
bottom of page